Cortigent (CRGT) Kapitalizatsiyaning foydaga nisbati

Cortigent (CRGT) korporativ emblemasi va logotipi

Cortigent, Inc. (CRGT) tizim yig'uvining barqarorligini ta'minlaydigan isbotlangan qismlar yetkazib beruvchilar tizimiga tayanadi. Indikator darajasida bo'lgan narx harakati biznes dinamikasini kuzatishga yordam beradi. O'sish Orion platformalari uchun patentlar va qat'iy FDA nazorati bilan himoyalangan. Biroq, geosiyosiy fragmentatsiya va mikrochiplarning yetishmasligi global testlar hamda ko'rish qobiliyatini tiklovchi qurilmalarning sertifikatsiyasiga to'sqinlik qilmoqda.

Cortigent Inc (CRGT) - Narx-foyda koeffitsiyenti 04.07.2022dan 12.11.2026gacha

Cortigent Inc (CRGT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:CRGT (cortigent.com)
Cortigent Medical ishlab chiqargan mahsulot

Cortigent, Inc. (CRGT) kompaniyasining fundamental barqarorligini bozor shovqinlaridan ajratish uchun foyda generatsiyasi samaradorligini baholash zarur. P/E koeffitsiyenti bozor kapitalizatsiyasining sof foydaga nisbatini hisobga olgan holda investitsiyalarning qoplanish muddatini o'lchaydi. Kompaniyaning narx-foyda tendentsiyasini tahlil qilish orqali investor aktivlarning haddan tashqari qimmat baholanganligini aniqlashi mumkin. Bioteknologiya sohasi uchun ushbu ko'rsatkich neyron interfeys klinik sinovlarining muvaffaqiyatiga kritik darajada bog'liq. Innovatsiyalar uchun davlat tomonidan ajratiladigan mablag'lar kelgusidagi daromadlilikka bevosita ta'sir ko'rsatadi.

Raqobatdosh kompaniyalar tahlili

Narx-foyda koeffitsiyenti biogen.com (BIIB)|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|RGC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|Kompaniya qiymatining sof foydaga nisbati ACAD|XENE: Narx-foyda koeffitsiyenti|vikingtherapeutics.com - Bozor narxining sof foydaga nisbati|SUPN: P/E multiplikatori|CPRX - Biznesning o‘zini qoplash muddati|DNLI (Denali Therapeutics Inc) - P/E multiplikatori|HRMY - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori BHVN|AMLX - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX: Narx-foyda multiplikatori|AVXL: Narx-foyda koeffitsiyenti|CeriBell EEG - Bozor narxining sof foydaga nisbati|PRTA (prothena.com) - Narx-foyda koeffitsiyenti|Alector - Kompaniya qiymatining sof foydaga nisbati|ANNX (Annexon) - P/E multiplikatori|Omeros Corp. (OMER) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Neurogene Corp (NGNE)|AC Immune Inc - Narx-foyda multiplikatori|P/E multiplikatori VYGR (Voyager Therapeutics)|NMRA - Narx-foyda koeffitsiyenti|SCLX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Tevogen Bio Holdings Inc. TVGN|ACOG: P/E multiplikatori|Narx-foyda koeffitsiyenti Cognition Therapeutics Inc.|Narxning foydaga nisbati Inhibikase Therapeutics|SAVA: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ASRT|coyatherapeutics.com (COYA) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Vistagen - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati OVID (Ovid Therapeutics Inc)|ABOS - Narxning foydaga nisbati|CRVO (cervomed.com) - Narx-foyda multiplikatori|ATHE: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Clene (CLNN)|Narx-foyda koeffitsiyenti PEPG|P/E multiplikatori Jupiter Neurosciences, Inc.|Narxning foydaga nisbati Relmada Therapeutics (RLMD)|ANVS (annovisbio.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Grace Therapeutics GRCE|Firefly Neuroscience, Inc. (AIFF) - Kapitalizatsiyaning foydaga nisbati|ANEW Medical, Inc. - P/E multiplikatori|NeuroSense Therapeutics (NRSN) - Narx-foyda koeffitsiyenti|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati MetaVia (MTVA)|Narxning foydaga nisbati NeurAxis|HSDT: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti PASG (Passage Bio, Inc.)|Bozor narxining sof foydaga nisbati NEUP|P/E multiplikatori NERV (Minerva Neurosciences)|Biznesning o‘zini qoplash muddati athira.com (ATHA)|Addex Therapeutics Ltd - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Alzamend Neuro, Inc. (ALZN)|CYCN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Protagenic Therapeutics, Inc. (PTIX)|Narxning foydaga nisbati Pasithea Therapeutics Corp|Narx-foyda multiplikatori ATXI (avenuetx.com)|Narx-foyda koeffitsiyenti BCLI (BrainStorm Cell Therapeutics)|Bozor narxining sof foydaga nisbati CARA|Chromocell Therapeutics Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular - P/E multiplikatori|Biznesning o‘zini qoplash muddati longboardpharma.com LBPH|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|Narx-foyda multiplikatori NKGN|NRBO (NeuroBo) - P/E multiplikatori|Narx-foyda koeffitsiyenti Sage Therapeutics Inc (SAGE)|Narx-foyda koeffitsiyenti SNPX (Synaptogenix, Inc.)|Biznesning o‘zini qoplash muddati trevena.com|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|WENA - Narx-foyda koeffitsiyenti|CERE - Narxning foydaga nisbati